ASCL1 and central nervous system cancer: Chromatin immunoprecipitation followed by deep sequencing (ChIP‐seq) has previously been performed for ASCL1 in glioma cell lines in culture, and a dual role for ASCL1 was proposed to either promote or attenuate tumorigenicity depending on context (Park et al., 2017; Rheinbay et al., 2013).